AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Vaccine maker initiates cost reduction program.(Biomira, Inc.)
2002 NOV 13 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM) (TSX:BRA) announced that the company has initiated a cost reduction program focused primarily on curtailing earlier research programs in favor of continuing development of its two lead product candidates: Theratope vaccine, the more advanced product candidate, and BLP25 liposomal vaccine, currently in phase II trials.
Theratope vaccine is being studied in a phase III metastatic breast cancer trial and the company anticipates that the final survival analysis of the phase III trial data will be in mid-2003.
"The strategic decision, supported by our Board, is to focus our resources on our two late-stage product candidates closest to possible commercialization, while de-emphasizing our earlier-stage research programs. Our decision to maximize our resource allocation in this way was reinforced by the downturn in the biotech sector and specifically our share price," said Alex McPherson, MD, PhD, Biomira. "The resulting strategy will conserve our resources, while keeping us at the forefront of therapeutic cancer vaccine development. ...Our ultimate goal is to be in a position to ...
- Phase II colorectal trial results for Theratope vaccine to be presented at...
- Newspaper article from: Vaccine Weekly April 16, 2003 700+ words
...com & NewsRx.net) -- Biomira, Inc., (BIOM; BRA) announced...from the company's phase II Theratope vaccine trial in metastatic colorectal...PhD, president and CEO of Biomira. Biomira has also been notified that...
- Biomira Analyst Conference Call Notification Theratope Vaccine Phase III...
- Press release article from: PR Newswire December 5, 2003 700+ words
Biomira Inc. (TSX:BRA) and Merck KGaA of Darmstadt...Company's Web site at http://www.biomira.com/. About the Companies: Merck KGaA...immunocytokines and angiogenesis inhibitors. Biomira is a biotechnology company specializing...
- THERATOPE Vaccine to Enter Phase III Clinical Trials.
- Press release article from: Business Wire August 20, 1997 700+ words
...early phase clinical trials. THERATOPE vaccine is manufactured by Biomira. THERATOPE vaccine is one of several synthetic...McPherson, M.D., Ph.D., Biomira's President and CEO. "THERATOPE vaccine is a logical fit to expand the...
- Metastatic breast cancer vaccine trial to continue.(Theratope vaccine)
- Magazine article from: Women's Health Weekly November 28, 2002 700+ words
...NewsRx.net) -- Biomira, Inc., (BIOM...III clinical trial of Theratope vaccine through its planned...development plan." Biomira and Merck KGaA, which...the development of Theratope vaccine, reached this decision...endpoint at this time. Biomira and Merck KGaA remain...
- Data from Theratope Vaccine trial presented.
- Newspaper article from: Vaccine Weekly January 7, 2004 700+ words
...NewsRx.net) -- Biomira, Inc., (BIOM...analysis of their Theratope Vaccine phase III clinical...patients receiving Theratope vaccine and those on...the impact of Theratope vaccine therapy on patients...quality of life. Biomira and its collaborator...
- Phase II colorectal trial results for theratope vaccine to be presented at ASCO.
- Newspaper article from: Gastroenterology Week April 14, 2003 700+ words
...com & NewsRx.net) -- Biomira, Inc., (BIOM; BRA) announced...from the company's phase II Theratope vaccine trial in metastatic colorectal...PhD, president and CEO of Biomira. Biomira has also been notified that...
- Therapeutic vaccine maker announces 2003 milestones.(Biomira, Inc.)
- Newspaper article from: Cancer Weekly January 14, 2003 700+ words
...half of 2003. Biomira is also expected...data on both the theratope vaccine phase II colorectal...In March 2001, Biomira completed enrollment...blinded phase III theratope vaccine trial, enrolling...patients treated with theratope vaccine when given in...liposomal ...
- Chiron and Biomira form partnership for THERATOPE cancer vaccine.
- Press release article from: Business Wire May 5, 1997 700+ words
...for oncology and on Biomira's strengths in...manufacturing of the THERATOPE vaccine. Biomira will have primary...agreement, Chiron and Biomira will share equally...activities of the THERATOPE vaccine in the United States...